輸入代號或公司名稱後按 Enter
4142

國光生

-0.30 (-1.71%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
17.20769成交張數本益比1.57股價淨值比0.00%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度資產總額(億)母公司權益(億)負債比率流動比率每股淨值ROE(近四季)ROA(近四季)營業現金流(億)自由現金流(億)
2026Q2814642.0%4.4710.77-3.1%-1.8%-2.9-3.1
2026Q1784838.0%2.1011.07-4.1%-2.5%-2.1-2.8
2025Q4824938.3%2.1211.51-4.7%-2.9%8.37.7
2025Q3844742.1%1.8511.00-10.2%-6.0%-3.6-4.1
2025Q2834840.7%2.0011.08-4.6%-2.7%-2.7-2.7
2025Q1835036.4%2.6611.64-5.5%-3.2%-2.1-3.3
2024Q4855234.4%3.1112.18-4.5%-2.7%6.66.2
2024Q3865334.6%3.2812.33-10.9%-6.8%-3.0-3.2
2024Q2875038.2%2.6411.70-11.4%-6.8%-3.4-4.0
2024Q1945340.2%2.4312.35-10.3%-6.2%6.56.2
2023Q4955539.1%2.6312.75-11.0%-6.9%-1.0-1.3
2023Q3935932.8%4.3513.71-2.7%-1.8%-2.9-3.1
2023Q2925734.4%3.8013.18-0.2%-0.1%-1.6-2.3
2023Q1915931.0%5.9513.704.7%3.2%-3.4-4.4
2022Q4916128.5%8.9714.264.7%3.4%6.86.3
2022Q3926228.7%10.5514.538.7%6.1%-3.7-4.2
2022Q2885830.4%9.0713.544.5%3.1%-4.1-4.8
2022Q1805923.1%6.5113.751.0%0.7%-2.0-3.7
2021Q4806119.7%12.7814.320.7%0.5%6.57.9
2021Q3815923.9%6.6513.7018.1%13.2%-4.4-11.2
2021Q2836024.1%6.3213.9318.5%13.1%-4.0-5.9
2021Q1836123.5%7.2014.1519.0%13.4%-3.0-4.1
2020Q4856321.8%9.6114.7124.9%16.5%22.721.5
2020Q3685021.3%8.9511.74-0.5%-0.3%-3.4-3.8
2020Q2684725.7%6.5111.22-1.7%-1.0%-3.6-4.0
2020Q1674529.6%6.7811.15-3.4%-1.7%7.57.5
2019Q4663641.8%11.1610.04-10.6%-4.6%0.5-0.0
2019Q3683742.8%9.3210.15-21.7%-9.7%-3.0-3.0
2019Q2723647.7%3.779.86-26.4%-11.2%-2.3-2.4
2019Q1541469.3%1.346.07-36.7%-11.4%2.22.2
2018Q4571667.3%1.436.91-32.5%-10.7%1.10.9
2018Q3571962.7%2.348.11-26.0%-9.7%-2.6-2.6
2018Q2571963.0%2.208.12-30.0%-11.2%-2.4-2.4
2018Q1572061.4%2.858.34-31.7%-12.2%-2.1-2.1
2017Q4572159.1%3.348.88-30.5%-12.1%2.62.6
2017Q3592455.5%4.4310.23-24.4%-11.6%-2.3-2.3
2017Q2622655.2%4.0010.76-23.9%-11.8%-2.0-2.0
2017Q1652755.2%3.4511.35-21.5%-10.9%1.71.7
2016Q4682954.4%3.3312.11-0.4-0.5
2016Q3563141.5%1.9712.87-3.3-3.3